The global Gene Synthesis market size is expected to be worth around US$ 10.58 billion by 2030, size was valued at US$ 2.47 billion in 2020 and is anticipated to grow at a CAGR of 19.1% during forecast period 2021 to 2030.
The report provides crucial statistics on the market status of the leading Gene Synthesis market players and offers information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Gene Synthesis Market. The report uses effective graphical presentation techniques, such as graphs, charts, tables as well as pictures for better understanding
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39078
Report Coverage
| Report Scope | Details |
| Market Size | US$ 10.58 billion by 2030 |
| Growth Rate | CAGR of 19.1% From 2021 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Method, Service, Application, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | GenScript; GENEWIZ; Boster Biological Technology; Twist Bioscience; ProteoGenix; Biomatik; ProMab Biotechnologies, Inc.; Thermo Fisher Scientific, Inc.; Integrated DNA Technologies, Inc.; OriGene Technologies, Inc. |
Growth Factors
Gene synthesis space is offering enormous potential for new biological functionality. This has resulted in the introduction of supportive government policies associated with synthetic biology, thereby driving the market.
Industry participants strive for developing proprietary and new technologies to strengthen their market presence. Furthermore, the establishment of organizations and forums helps encourage researchers to opt and study genetic engineering-related concepts and develop innovative technologies, which is also a notable growth driver of this space.
Considering this space as a lucrative source of revenue, companies are focusing on collaborations with various universities for on-site training, online workshops, and sponsored projects to boost their expertise portfolio. This is also expected to generate interest among research professionals by helping them realize the potential of this field and therefore spurring adoption in the market.
Key Players
- GenScript
- Brooks Automation, Inc. (GENEWIZ)
- Boster Biological Technology
- Twist Bioscience
- ProteoGenix
- Biomatik
- ProMab Biotechnologies, Inc.
- Thermo Fisher Scientific, Inc.
- Integrated DNA Technologies, Inc.
- OriGene Technologies, Inc.
Market Segmentation
- By Method
- Solid-phase Synthesis
- Chip-based Synthesis
- PCR-based Enzyme Synthesis
- By Service
- Antibody DNA Synthesis
- Viral DNA Synthesis
- Others
- By Application
- Gene & Cell Therapy Development
- Vaccine Development
- Disease Diagnosis
- Others
- By End-use
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Asia Pacific
- Japan
- China
- South Korea
- India
- Latin America
- Brazil
- Mexico
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- North America
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
- To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
- Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
- To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Application Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Gene Synthesis Market, By Method
7.1. Gene Synthesis Market, by Method, 2021-2030
7.1.1. Solid-phase Synthesis
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Chip-based Synthesis
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. PCR-based Enzyme Synthesis
7.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Gene Synthesis Market, By Service
8.1. Gene Synthesis Market, by Service, 2021-2030
8.1.1. Antibody DNA Synthesis
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Viral DNA Synthesis
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Gene Synthesis Market, By Application
9.1. Gene Synthesis Market, by Application, 2021-2030
9.1.1. Gene & Cell Therapy Development
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Vaccine Development
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Disease Diagnosis
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Gene Synthesis Market, By End-use
10.1. Gene Synthesis Market, by End-use, 2021-2030
10.1.1. Biotechnology & Pharmaceutical Companies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Academic & Government Research Institutes
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Contract Research Organizations
10.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Gene Synthesis Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Method (2017-2030)
11.1.2. Market Revenue and Forecast, by Service (2017-2030)
11.1.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.4. Market Revenue and Forecast, by End-use (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Method (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Service (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End-use (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Method (2017-2030)
11.2.2. Market Revenue and Forecast, by Service (2017-2030)
11.2.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.4. Market Revenue and Forecast, by End-use (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Method (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Service (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End-use (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Method (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Service (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End-use (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Method (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Service (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End-use (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Method (2017-2030)
11.3.2. Market Revenue and Forecast, by Service (2017-2030)
11.3.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.4. Market Revenue and Forecast, by End-use (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Method (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Service (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End-use (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Method (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Service (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End-use (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Method (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Service (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End-use (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Method (2017-2030)
11.4.2. Market Revenue and Forecast, by Service (2017-2030)
11.4.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.4. Market Revenue and Forecast, by End-use (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Method (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Service (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End-use (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Method (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Service (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End-use (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Method (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Service (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End-use (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Method (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Service (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End-use (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Method (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Service (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 12. Company Profiles
12.1. GenScript
12.1.1. Company Overview
12.1.2. Method Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Brooks Automation, Inc. (GENEWIZ)
12.2.1. Company Overview
12.2.2. Method Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Boster Biological Technology
12.3.1. Company Overview
12.3.2. Method Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Twist Bioscience
12.4.1. Company Overview
12.4.2. Method Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ProteoGenix
12.5.1. Company Overview
12.5.2. Method Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Biomatik
12.6.1. Company Overview
12.6.2. Method Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ProMab Biotechnologies, Inc.
12.7.1. Company Overview
12.7.2. Method Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Thermo Fisher Scientific, Inc.
12.8.1. Company Overview
12.8.2. Method Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Integrated DNA Technologies, Inc
12.9.1. Company Overview
12.9.2. Method Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. OriGene Technologies, Inc.
12.10.1. Company Overview
12.10.2. Method Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Buy This Report, click here@
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com